Condition: Metastatic Non Small Cell Lung Cancer · Sponsor: Iovance Biotherapeutics, Inc.
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung cancer
This description comes directly from the study's public registry record.
Iovance Biotherapeutics Study Team lungcelltherapy.com · 1-844-845-4682 · Clinical.Inquiries@iovance.com
Always discuss trial participation with your own doctor first.
| Banner Health MD Anderson | Gilbert, Arizona, United States | Recruiting |
| Sylvester Comprehensive Cancer Center | Miami, Florida, United States | Active Not Recruiting |
| H Lee Moffitt Cancer Center and Research Institute | Tampa, Florida, United States | Recruiting |
| Rush University Medical Center | Chicago, Illinois, United States | Active Not Recruiting |
| University of Illinois Hospital & Health Sciences System | Chicago, Illinois, United States | Active Not Recruiting |
| Advocate Aurora Health | Park Ridge, Illinois, United States | Recruiting |
| University of Louisville | Louisville, Kentucky, United States | Recruiting |
| University of Maryland | Baltimore, Maryland, United States | Active Not Recruiting |
| Karmanos Cancer Institute | Detroit, Michigan, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | Recruiting |
| MD Anderson Cooper | Camden, New Jersey, United States | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04614103